Calidi Biotherapeutics (CLDI) Change in Cash (2022 - 2025)
Calidi Biotherapeutics' quarterly Change in Cash came in at -$4.8 million in Q4 2025, down 162.06% year-on-year from $7.7 million in Q4 2024, and down 191.56% quarter-over-quarter from $5.2 million in Q3 2025.
Calidi Biotherapeutics has reported Change in Cash for 4 years, with the latest figure at -$4.8 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Cash fell 162.06% year-over-year to -$4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$4.0 million (down 152.21% YoY), and the FY2025 full-year result was -$4.0 million, down 152.21% from the prior year.
- Change in Cash for Q4 2025 stood at -$4.8 million, down from $5.2 million in the prior quarter.
- The five-year high for Change in Cash was $8.1 million in Q3 2023, with the low at -$8.2 million in Q4 2023.
- Average Change in Cash over 4 years is $223875.0, with a median of $10660.5 recorded in 2022.
- Peak annual rise in Change in Cash reached 771.47% in 2023, while the deepest fall reached 2926.9% in 2023.
- Tracing CLDI's Change in Cash over 4 years: stood at $290000.0 in 2022, then slumped by 2926.9% to -$8.2 million in 2023, then jumped by 193.85% to $7.7 million in 2024, then plunged by 162.06% to -$4.8 million in 2025.
- The last three Change in Cash figures came in at -$4.8 million (Q4 2025), $5.2 million (Q3 2025), and -$5.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -153.10 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Calidi Biotherapeutics | - | - | - | -4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.78 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | -5.40 Mn |
| Mar 31, 2025 | 970,000.00 |
| Dec 31, 2024 | 7.69 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | -307,000.00 |
| Mar 31, 2024 | -806,000.00 |
| Dec 31, 2023 | -8.20 Mn |
| Sep 30, 2023 | 8.08 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 547,000.00 |
| Dec 31, 2022 | 290,000.00 |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -268,679.00 |
| Mar 31, 2022 | -465,131.00 |